ferric citrate has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, K; Czaya, B; Gabayan, V; Ganz, T; Hanudel, MR; Jung, G; Qiao, B; Wong, S | 1 |
| Agoro, R; Allen, MR; Clinkenbeard, EL; Damrath, JG; Hum, JM; Liesen, MP; Ni, P; Noonan, ML; Swallow, EA; Wallace, JM; White, KE | 1 |
| Capella, M; Courbon, G; David, V; Dussold, C; Francis, C; Gerber, C; Isakova, T; Martin, A; Mehta, R; Neuburg, S; Qi, L; Wang, X; Wolf, M | 1 |
| Chen, Z; Cheng, A; Huang, C; Lao, C; Liu, W; Luo, Q; Ma, W; Shi, L; Shi, R; Xia, Y; Zou, Y | 1 |
| Staniek, H | 1 |
| Camacho, A; Cancela, ML; Ea, HK; Gavaia, PJ; Pinto, IJ; Porto, G; Simão, M | 1 |
| Chang, Y; Chen, J; Duan, X; Ge, L; Geng, L; Yu, P; Yuan, L | 1 |
| An, P; Fang, X; Gao, H; Li, G; Li, Y; Liu, W; Min, J; Wang, F; Wang, H; Wang, X; Wu, Q; Xie, E; Yang, L; Zhang, J; Zhang, Z | 1 |
| Hadzija, M; Hrvacić, B; Polancec, D; Poljak-Blazi, M; Stanić, B; Zupanović, Z | 1 |
| Chua, AC; Leedman, PJ; Olynyk, JK; Trinder, D | 1 |
| Brand, B; Rosenmund, A; Straub, PW | 1 |
11 other study(ies) available for ferric citrate and Disease Models, Animal
| Article | Year |
|---|---|
Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease.
Topics: Animals; Disease Models, Animal; Female; Ferric Compounds; Humans; Inflammation; Iron; Male; Mice; Mice, Knockout; Phosphates; Renal Insufficiency, Chronic | 2022 |
Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD.
Topics: Animals; Citric Acid; Disease Models, Animal; Electrolytes; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Iron; Mice; Minerals; Renal Insufficiency, Chronic; RNA, Messenger | 2022 |
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
Topics: Animals; Autoantigens; Collagen Type IV; Disease Models, Animal; Drug Evaluation, Preclinical; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Heart; Kidney; Mice; Mice, Knockout; Renal Insufficiency, Chronic | 2019 |
Iron overload resulting from the chronic oral administration of ferric citrate induces parkinsonism phenotypes in middle-aged mice.
Topics: Animals; Brain; Disease Models, Animal; Ferric Compounds; Iron Overload; Male; Mice; Oxidative Stress; Parkinsonian Disorders | 2019 |
The Combined Effects of Cr(III) Supplementation and Iron Deficiency on the Copper and Zinc Status in Wistar Rats.
Topics: Anemia, Iron-Deficiency; Animals; Body Weight; Chromium Compounds; Copper; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Ferric Compounds; Rats; Rats, Wistar; Structure-Activity Relationship; Zinc | 2019 |
Intracellular iron uptake is favored in Hfe-KO mouse primary chondrocytes mimicking an osteoarthritis-related phenotype.
Topics: Aggrecans; Animals; Cartilage, Articular; Cation Transport Proteins; Cell Differentiation; Chondrocytes; Collagen Type I; Disease Models, Animal; Extracellular Matrix; Female; Ferric Compounds; Ferritins; Gene Expression Regulation; Hemochromatosis; Hemochromatosis Protein; Humans; Iron; Iron Overload; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoarthritis; Oxidoreductases; Primary Cell Culture; Receptors, Transferrin; Sex-Determining Region Y Protein; Signal Transduction; SOX9 Transcription Factor | 2019 |
Effect of iron liposomes on anemia of inflammation.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Ferric Compounds; Hematinics; Heme; Hepcidins; Inflammation; Intestinal Absorption; Iron; Liposomes; Male; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical; Time Factors; Ultrasonics | 2013 |
Characterization of ferroptosis in murine models of hemochromatosis.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Cell Survival; Cells, Cultured; Disease Models, Animal; Ferric Compounds; Hemochromatosis; Hepatocytes; Iron; Iron Chelating Agents; Lipid Peroxidation; Macrophages; Male; Mice; Mice, Knockout; Oxidative Stress; Random Allocation; Real-Time Polymerase Chain Reaction; Receptors, Somatostatin; Sensitivity and Specificity | 2017 |
Differing effects of two iron compounds on experimental arthritis, TNF-alpha levels and immune response in mice.
Topics: Animals; Arthritis, Experimental; Autoimmunity; Cell Division; Cells, Cultured; Citric Acid; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Ferric Compounds; Injections, Intramuscular; Iron Compounds; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Serum Albumin, Bovine; Sorbitol; Spleen; Thymus Gland; Tumor Necrosis Factor-alpha | 2003 |
Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis.
Topics: Animals; Biological Transport; Cation Transport Proteins; Cobalt; Disease Models, Animal; Ferric Compounds; Hemochromatosis; Hepatocytes; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Iron Radioisotopes; Iron-Binding Proteins; Manganese; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenanthrolines; RNA, Messenger; Transferrin; Zinc | 2004 |
Hyperlactataemia, hyperkalemia and heart block in acute iron overload: the fatal role of the hepatic iron-incorporation rate in rats on ferric citrate infusions.
Topics: Animals; Disease Models, Animal; Electrocardiography; Ferric Compounds; Heart Block; Heart Conduction System; Heart Rate; Hyperkalemia; Infusions, Intravenous; Iron; Lactates; Lactic Acid; Liver; Male; Myocardium; Rats; Rats, Inbred Strains; Time Factors | 1988 |